AU2003212361A1 - Enhancement of vitamin e content in organisms by enhancing 2-methyl-6-phytyl hydroquinone-methyltransferase activity - Google Patents

Enhancement of vitamin e content in organisms by enhancing 2-methyl-6-phytyl hydroquinone-methyltransferase activity

Info

Publication number
AU2003212361A1
AU2003212361A1 AU2003212361A AU2003212361A AU2003212361A1 AU 2003212361 A1 AU2003212361 A1 AU 2003212361A1 AU 2003212361 A AU2003212361 A AU 2003212361A AU 2003212361 A AU2003212361 A AU 2003212361A AU 2003212361 A1 AU2003212361 A1 AU 2003212361A1
Authority
AU
Australia
Prior art keywords
phytyl
hydroquinone
organisms
vitamin
enhancement
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003212361A
Inventor
Michael Geiger
Rainer Lemke
Klaus-Dieter Salchert
Susanne Tropf
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SunGene GmbH
Original Assignee
SunGene GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SunGene GmbH filed Critical SunGene GmbH
Publication of AU2003212361A1 publication Critical patent/AU2003212361A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1003—Transferases (2.) transferring one-carbon groups (2.1)
    • C12N9/1007—Methyltransferases (general) (2.1.1.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02—Oxygen as only ring hetero atoms
    • C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2003212361A 2002-03-21 2003-03-17 Enhancement of vitamin e content in organisms by enhancing 2-methyl-6-phytyl hydroquinone-methyltransferase activity Abandoned AU2003212361A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10212703A DE10212703A1 (en) 2002-03-21 2002-03-21 Increasing vitamin E levels in organisms by increasing 2-methyl-6-phytythydroquinone methyltransferase activity
DE10212703.4 2002-03-21
PCT/EP2003/002732 WO2003080844A2 (en) 2002-03-21 2003-03-17 Enhancement of vitamin e content in organisms by enhancing 2-methyl-6-phytyl hydroquinone-methyltransferase activity

Publications (1)

Publication Number Publication Date
AU2003212361A1 true AU2003212361A1 (en) 2003-10-08

Family

ID=27798032

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003212361A Abandoned AU2003212361A1 (en) 2002-03-21 2003-03-17 Enhancement of vitamin e content in organisms by enhancing 2-methyl-6-phytyl hydroquinone-methyltransferase activity

Country Status (3)

Country Link
AU (1) AU2003212361A1 (en)
DE (1) DE10212703A1 (en)
WO (1) WO2003080844A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1586645A3 (en) 1999-02-25 2006-02-22 Ceres Incorporated Sequence-determined DNA fragments and corresponding polypeptides encoded thereby
WO2006091676A2 (en) 2005-02-22 2006-08-31 Ceres Inc. Modulating plant alkaloids
US8124839B2 (en) 2005-06-08 2012-02-28 Ceres, Inc. Identification of terpenoid-biosynthesis related regulatory protein-regulatory region associations

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1033405A3 (en) * 1999-02-25 2001-08-01 Ceres Incorporated Sequence-determined DNA fragments and corresponding polypeptides encoded thereby
DE19931834A1 (en) * 1999-07-09 2001-01-11 Sungene Gmbh & Co Kgaa Identification and overexpression of a DNA sequence coding for a 2-methyl-6-phytylhydroquinone methyltransferase in plants
DE10009002A1 (en) * 2000-02-25 2001-08-30 Sungene Gmbh & Co Kgaa A new homogentisatephytyltransferase protein encoded by the open reading frame slr1376 from Synechocystis species. PCC6803 is useful to provide transgenic plants producing vitamin E
AR030430A1 (en) * 2000-06-29 2003-08-20 Sungene Gmbh & Co Kgaa PROCEDURE FOR THE OBTAINING OF FINE CHEMICALS BY CULTURE OF ORGANISMS THAT PRESENT A MODIFIED SHIQUIMATE ROUTE, NUCLEINIC ACID COMPOSITION, USE OF SUCH NUCLEINIC ACID FOR THE OBTAINING OF TRANSGENIC PLANTS, GENETICALLY PRODUCED PROCEDURE ORGANISM

Also Published As

Publication number Publication date
DE10212703A1 (en) 2003-10-02
WO2003080844A2 (en) 2003-10-02
WO2003080844A3 (en) 2003-12-24

Similar Documents

Publication Publication Date Title
AU2003239568A1 (en) Pyrrolotriazinone compounds and their use to treat diseases
AU2003298038A1 (en) Using haptic effects to enhance information content in communications
AU2003232450A1 (en) Photoplethysmograph signal-to-noise enhancement
AU2003238011A1 (en) Treating vitamin d responsive diseases
AU2003248820A1 (en) Reducing processor energy consumption by controlling processor resources
AU2003251781A1 (en) Reducing processor energy consumption using compile-time information
AU2003236135A1 (en) Aralkyl-alcohol peiperazine derivatives and their uses as antidepressant
AU2003233312A1 (en) Pet treat
AU2003230957A1 (en) Quantitation of biological molecules
AU2003298163A1 (en) Providing status of portal content
WO2004077937A8 (en) Method of promoting pet care and kit therefor
AU2003302822A1 (en) Antibodies to treat cancer
AU2003212361A1 (en) Enhancement of vitamin e content in organisms by enhancing 2-methyl-6-phytyl hydroquinone-methyltransferase activity
AUPS239302A0 (en) Improvements to tow-bars
AU2003217174A1 (en) Novel variants of rankl protein
AU2003302927A1 (en) Genetic modification of carotenoid content in plants
DE50212983D1 (en) INCREASE OF VITAMIN E-CONTENT IN ORGANISMS BY INCREASING TYROSINAMINOTRANSFERASE ACTIVITY
AU2003216027A1 (en) Improvements in or relating to spectacles
AU2003285824A1 (en) Potatoes with increased protein content
AU2002257623A1 (en) Increase in the vitamin E content in organisms due to an increase in the tyrosine aminotransferase activity
AU2003902788A0 (en) Active compounds and uses therefor
AU2003296454A1 (en) Increasing skin cell renewal with water-soluble vitamin e
AU2003211293A1 (en) Method for enhancing learning and memory by suppressing the activity of ncx2 protein
AU2003280983A1 (en) Transgenic expression constructs and methods for increasing the vitamin e content in plant organisms
AU2003249996A1 (en) Transgenic expression constructs and methods for increasing the vitamin e content in plant organisms

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase